In rodent models, GLP-1 receptor agonists have been shown to decrease both the consumption and the rewarding effects of opioids like heroin
57 GaraciE.PalamaraA
1997;273(1 Pt 1):E130-E138
Temporary soreness, redness, or bruising at the injection site Mild itching or swelling at the site Occasional nausea, headache, or lightheadedness shortly after injection Allergic reaction (uncommon) Infection at the injection site if sterile technique is compromised Nutrient imbalance with prolonged, unsupervised use particularly relevant for patients with kidney disease The FDA has warned against unapproved injectable products marketed for fat reduction, citing risks including infection, scarring, and skin deformities
Frequently Asked Questions About the Hers GLP-1 Program What GLP-1 options does Hers provide
Others feel unsettled because food used to structure their day, provide comfort, or fill downtime